-
Omnicell Beats by a Penny - Analyst Blog
Thursday, October 28, 2010 - 5:33pm | 337Omnicell Inc. (OMCL) reported third quarter 2010 earnings per share (EPS) of 11 cents, surpassing the year-ago quarter's 10 cents. After adjusting for stock-based compensation expenses, EPS was 4 cents, closely beating both the Zacks Consensus Estimate of 2 cents and year-ago quarter's earnings...
-
Computer Programs and Systems, Inc. Announces Third Quarter 2010 Results: EPS of $0.45 and Dividend of $0.36
Thursday, October 28, 2010 - 3:41pm | 42Computer Programs and Systems, Inc. (NASDAQ: CPSI): Third Quarter Highlights: * Revenues of $40.9 million; * 12-month backlog of $122.9 million; * Earnings per diluted share of $0.45; * Cash provided by operations of $5.3 million; and * Quarterly dividend of $0.36 per share.
-
Cerner Corp. Beats Estimates; Updates Guidance (CERN)
Thursday, October 28, 2010 - 3:24pm | 191Cerner Corp. (NASDAQ: CERN) reports Q3 earnings of $0.76 versus consensus of $0.74. Cerner Corp. reports revenues of $462.7 million versus consensus of $465.63 million. Revenues increased 13% year over year; bookings in Q3 were $495.7 million, representing a 17% year over year increase. CERN sees...
-
Oppenheimer Changes Price Targets Of UTX, ORLY, MDAS, CCI And More
Thursday, October 28, 2010 - 12:13pm | 119Oppenheimer is changing the price targets of the following companies: IAC/InterActiveCorp. (NASDAQ: IACI) $30 to $35 O'Reilly Automotive, Inc. (NASDAQ: ORLY) $50 to $59 United Technologies Corp. (NYSE: UTX) $80 to $83 Crown Castle International Corp. (NYSE: CCI) $45 to $52 Symantec (NASDAQ:...
-
Stifel Nicolaus Changes Price Targets Of IACI, ESRX, MDAS And More
Thursday, October 28, 2010 - 12:05pm | 187Stifel Nicolaus is changing the price targets of the following companies: Cavium Networks, Inc. (NASDAQ: CAVM) $34 to $36 Rome Bancorp, Inc. (NASDAQ: ROME) $11 to $12 Mellanox Technologies, Ltd. (NASDAQ: MLNX) $21 to $26 Express Scripts (NASDAQ: ESRX) $58 to $60 MedAssets, Inc. (NASDAQ: MDAS)...
-
FBR Capital Changes SYMC, AKAM, PNR, OMCL And NARA Price Targets
Thursday, October 28, 2010 - 11:55am | 77FBR Capital is changing the price targets of the following companies: Symantec (NASDAQ: SYMC) $15 to $16 Akamai Technologies, Inc. (NASDAQ: AKAM) $36 to $46 Pentair, Inc. (NYSE: PNR) $40 to $38 Omnicell, Inc. (NASDAQ: OMCL) $10 to $11 Nara Bancorp, Inc. (NASDAQ: NARA) $8 to $9
-
MedAssets Reports Third Quarter EPS of $.25
Wednesday, October 27, 2010 - 3:34pm | 97MedAssets, Inc. (NASDAQ: MDAS) today announced results for its third quarter and nine-month period ended September 30, 2010, as summarized below: Net income in the third quarter of 2010 was $8.5 million, or $0.14 per diluted share, versus net income of $5.9 million, or $0.10 per diluted share, in...
-
HealthStream Announces Third Quarter 2010 Results; EPS $.04
Monday, October 25, 2010 - 3:35pm | 176HealthStream, Inc. (NASDAQ: HSTM) announced today results for the third quarter ended September 30, 2010. Highlights: Revenues of $16.6 million in the third quarter of 2010, up 18% over the third quarter of 2009 Operating income of $1.7 million in the third quarter of 2010, up 57% over the...
-
Jefferies Sees Strong Upside In Allscripts-Misys (MDRX)
Friday, October 22, 2010 - 6:13am | 59Jefferies & Co. sees strong upside in shares of Allscripts-Misys Healthcare Solutions (NASDAQ: MDRX), despite Jefferies seeing earnings season for the sector get off to a less than inspiring start. It has a Buy rating, and a $25 price target, implying a 32.9% return on shares. Shares closed at...
-
Benzinga's Top Pre-Market NASDAQ Gainers (AGAM, ISTA, STX, MEDQ)
Monday, October 18, 2010 - 7:33am | 157AGA Medical Holdings Inc (NASDAQ: AGAM) rose 40.38% to $20.65 in the pre-market session. St. Jude Medical Inc (NYSE: STJ) has agreed to acquire AGAM for $1.3 billion or $20.80 per share, representing a 32% premium to AGAM's 6-month average price. ISTA Pharmaceuticals Inc (NASDAQ: ISTA) added 22.10...
-
Jefferies & Company Names Its Physician And Hospital Post Winners
Friday, October 15, 2010 - 9:01am | 93Following the regional HIMSS event, Jefferies & Company is recommending Allscripts Healthcare Solutions (NASDAQ: MDRX) and McKesson Corporation (NYSE: MCK). “On the physician side Allscripts (Buy) appeared to be the primary vendor used by attendees,” Jefferies & Company writes. “We...
-
Allscripts Expected To Gain Market Share
Friday, October 15, 2010 - 7:04am | 126Jefferies expects Allscripts Healthcare (NASDAQ: MDRX) to steadily gain market share in the physician EHR market. Jefferies anticipates that MDRX is in position to further penetrate the southeast and Nashville healthcare market. This provides greater confidence in our above consensus estimates for...
-
Jefferies Likes Allscripts-Misys (MDRX)
Friday, October 15, 2010 - 5:54am | 105Jefferies & Co. has a Buy rating on Allscripts-Misys Healthcare Solutions (NASDAQ: MDRX) and a $25 price target, as it continues to roll right along. In the research note, Jefferies writes, "It is quite clear that MDRX is rolling along in the Southeast and middle TN following our visit to the...
-
MedQuist Announces Closing of $200M Financing
Thursday, October 14, 2010 - 2:16pm | 77MedQuist Inc. (Nasdaq: MEDQ) has closed its previously announced $310 million financing, consisting of a $200 million senior secured credit facility, which includes an undrawn $25 million revolving credit facility, and $85 million aggregate principal amount of senior subordinated notes. MedQuist...
-
Cerner and Omnicell Ratings Maintained Following Healthcare Conference
Wednesday, October 13, 2010 - 7:15am | 115Cerner Corporation's (NASDAQ: CERN) well-attended user conference highlighted the need for change in healthcare, Piper Jaffray reports. Healthcare reform and accountable care organizations (ACOs) garnered much attention among attendees, who reportedly agree that the formation of ACOs are inevitable...